NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

2025 Tax Loss Selling & Unlikely BUYOUT
https://dynamicglobalinsights.substack.com/p/end-of-year-tax-planning-season-begins

Since 2022 one can see the above having that impact:

https://www.barchart.com/quotes/NWBO/technical-chart#/technical-chart?sym=NWBO&plot=CANDLE&volume=total&indicators=CHKMF%2820%29%3BCOTLC%28%29%3BSTOFA%2814%2C3%29%3BOBV%28%29&pricesOn=1&asPctChange=0&logScale=0&grid=1&height=500&studyheight=100&data=WO&density=X

Came across this

https://www.wsj.com/articles/northwest-biotherapeutics-to-probe-ceo-allegations-1449594350?mod=mw_quote_news&adobe_mc=MCMID%3D83208478979710462380156804587651998755%7CMCORGID%3DCB68E4BA55144CAA0A4C98A5%2540AdobeOrg%7CTS%3D1761072261

evanstony
Re: Kam8 post# 793360
Monday, 10/20/2025 7:16:46 AM

I just hope BO immediately after MHRA Approval.

$18 per share please......

Immediately the terms may be disgusted and hopefully with more than one suitor. IMO we will hear about offer(s) within 3-4 months. IMO the low end estimate $14 and the high $25. I like the $18 number. Multiple suitors could easily push it over $20.

Approval IMO is this year and then .... LP is ready

The above posts Pre supposes TOO MUCH

Even after MHRA Approval & MAESTRO unveils her cards in a timely sequenced manner

Still an acceptable BUYOUT over $10
appears REMOTE:

INABILITY of Big Pharma to get Shareholder Approval nor that from recognized independent Investment Banking firms.

In summation like I have been saying since 2015
(I have the documentation)

MAESTRO has to unshackle this ALBATROSS

Regardless of whatever ANYONE posts

DIFFERENT STROKES for DIFFERENT FOLKS